Treatment of HBV infection reduces the risk of hepatocellular carcinoma

被引：0
|
作者：
机构：
来源：
Nature Clinical Practice Gastroenterology & Hepatology | 2009年 / 6卷 / 1期
关键词：
D O I：
10.1038/ncpgasthep1304
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2 / 2
相关论文
共 50 条
  • [1] Universal HBV vaccination dramatically reduces the prevalence of HBV infection and incidence of hepatocellular carcinoma
    Wong, Grace Lai-Hung
    Hui, Vicki Wing-Ki
    Yip, Terry Cheuk-Fung
    Liang, Lilian Yan
    Zhang, Xinrong
    Tse, Yee-Kit
    Lai, Jimmy Che-To
    Chan, Henry Lik-Yuen
    Wong, Vincent Wai-Sun
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2022, 56 (05) : 869 - 877
  • [2] HBV Infection and Hepatocellular Carcinoma
    Iavarone, Massimo
    Colombo, Massimo
    [J]. CLINICS IN LIVER DISEASE, 2013, 17 (03) : 375 - +
  • [3] Meta-analysis: treatment of hepatitis B infection reduces risk of hepatocellular carcinoma
    Sung, J. J. Y.
    Tsoi, K. K. F.
    Wong, V. W. S.
    Li, K. C. T.
    Chan, H. L. Y.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2008, 28 (09) : 1067 - 1077
  • [4] ANTIVIRAL THERAPY REDUCES HEPATOCELLULAR CARCINOMA RISK AMONG HBV PATIENTS IN THE INDETERMINATE PHASE
    Huang, Daniel
    Tran, Andrew Khoa
    Yeh, Ming-Lun
    Tsai, Pei-Chien
    Chuang, Wan-Long
    Huang, Chung-Feng
    Dai, Chia-Yen
    Toyoda, Hidenori
    Yasuda, Satoshi
    Trinh, Huy
    Ogawa, Eiichi
    Ishigami, Masatoshi
    Ito, Takanori
    Kozuka, Ritsuzo
    Enomoto, Masaru
    Tanaka, Yasuhito
    Suzuki, Takanori
    Yoshimaru, Yoko
    Preda, Carmen
    Marin, Raluca
    Sandra, Irina
    Quek, Sabrina
    Khine, Htet Htet Toe Wai
    Itokawa, Norio
    Atsukawa, Masanori
    Uojima, Haruki
    Watanabe, Tsunamasa
    Takahashi, Hirokazu
    Inoue, Kaori
    Maeda, Mayumi
    Hoang, Joseph
    Trinh, Lindsey
    Cheung, Ramsey
    Lim, Seng Gee
    Yu, Ming-Lung
    Nguyen, Mindie H.
    [J]. HEPATOLOGY, 2022, 76 : S34 - S35
  • [5] Dual infection with HBV and HCV in hepatocellular carcinoma
    Liaw, YF
    [J]. CANCER JOURNAL - FRANCE, 1997, 10 (04): : 189 - 192
  • [6] THE RISK OF HEPATOCELLULAR CARCINOMA IN CIRRHOTIC PATIENTS WITH HBV AND HCV INFECTION: NOT AN EQUAL OPPORTUNITY
    Asfari, Mohammad Maysara
    Sarmini, Muhammad Talal
    Baidoun, Firas
    McCullough, Arthur
    [J]. GASTROENTEROLOGY, 2019, 156 (06) : S1313 - S1313
  • [7] ANTIVIRAL THERAPY REDUCES HEPATOCELLULAR CARCINOMA RISK IN HBV CIRRHOSIS PATIENTS WITH LOWER VIRAL LOAD
    Gao, Xuesong
    Yang, Hwai-I
    Jeong, Donghak
    Le, An K.
    Hoang, Joseph
    Nguyen, Pauline
    Nguyen, Mindie H.
    [J]. GASTROENTEROLOGY, 2017, 152 (05) : S1052 - S1053
  • [8] Association between four common microRNA polymorphisms and the risk of hepatocellular carcinoma and HBV infection
    Kou, Jian-Tao
    Fan, Hua
    Han, Dongdong
    Li, Lixin
    Li, Ping
    Zhu, Jiqiao
    Ma, Jun
    Zhang, Zhi-Hua
    He, Qiang
    [J]. ONCOLOGY LETTERS, 2014, 8 (03) : 1255 - 1260
  • [9] A comparison of hepatocellular carcinoma associated with HBV or HCV infection
    Tanabe, G
    Nuruki, K
    Baba, Y
    Imamura, Y
    Miyazono, N
    Ueno, K
    Arima, T
    Nakajyou, M
    Aikou, T
    [J]. HEPATO-GASTROENTEROLOGY, 1999, 46 (28) : 2442 - 2446
  • [10] Early Normalization of Alanine Aminotransferase during Antiviral Therapy Reduces Risk of Hepatocellular Carcinoma in HBV Patients
    Kim, Sehwa
    Lee, Yoonseok
    Bang, Soo Min
    Bak, Haein
    Yim, Sun Young
    Lee, Young Sun
    Yoo, Yang Jae
    Jung, Young Kul
    Kim, Ji Hoon
    Seo, Yeon Seok
    Yim, Hyung Joon
    Um, Soon Ho
    Byun, Kwan Soo
    Yeon, Jong Eun
    [J]. JOURNAL OF CLINICAL MEDICINE, 2021, 10 (09)
12345